• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

靶向肿瘤微环境的 [I]I-pHLIP (Var7) 用于 SPECT/CT 成像 MDA-MB-231 三阴性乳腺癌小鼠模型的实验研究

An Experimental Study on [I]I-pHLIP (Var7) for SPECT/CT Imaging of an MDA-MB-231 Triple-Negative Breast Cancer Mouse Model by Targeting the Tumor Microenvironment.

机构信息

Department of Nuclear Medicine, The Affiliated Hospital of Qingdao University, Qingdao, China.

出版信息

Mol Imaging. 2021 Feb 16;2021:5565932. doi: 10.1155/2021/5565932. eCollection 2021.

DOI:10.1155/2021/5565932
PMID:33746628
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7953584/
Abstract

OBJECTIVE

To evaluate the diagnostic efficacy of MDA-MB-231 triple-negative breast cancer with I-labeled pHLIP (Var7) by single-photon emission computed tomography/computed tomography (SPECT/CT) imaging.

METHODS

The binding fraction of [I]I-pHLIP (Var7) and MDA-MB-231 cells was measured at pH 7.4 and pH 6.0, and tumor-bearing mice were subjected to small-animal SPECT/CT imaging studies.

RESULTS

At pH = 6.0, the binding fractions of [I]I-pHLIP (Var7) and MDA-MB-231 cells at 10 min, 40 min, 1 h, and 2 h were 1.9 ± 0.1%, 3.5 ± 0.1%, 6.3 ± 0.8%, and 6.6 ± 0.3%, respectively. At pH = 7.4, there was no measured binding between [I]I-pHLIP (Var7) and MDA-MB-231 cells. Small-animal SPECT/CT imaging showed clearly visible tumors at 1 and 2 h after injection.

CONCLUSIONS

[I]I-pHLIP (Var7) could bind to MDA-MB-231 cells in an acidic environment, and small-animal SPECT/CT imaging showed clear tumors at 1 and 2 h after probe injection.

摘要

目的

通过单光子发射计算机断层扫描/计算机断层扫描(SPECT/CT)成像评估 MDA-MB-231 三阴性乳腺癌的 MDA-MB-231 三阴性乳腺癌的诊断效能。

方法

在 pH 值为 7.4 和 6.0 时测量 [I]I-pHLIP(Var7)与 MDA-MB-231 细胞的结合分数,并对荷瘤小鼠进行小动物 SPECT/CT 成像研究。

结果

在 pH = 6.0 时,[I]I-pHLIP(Var7)与 MDA-MB-231 细胞在 10 分钟、40 分钟、1 小时和 2 小时的结合分数分别为 1.9 ± 0.1%、3.5 ± 0.1%、6.3 ± 0.8%和 6.6 ± 0.3%。在 pH = 7.4 时,[I]I-pHLIP(Var7)与 MDA-MB-231 细胞之间没有可测量的结合。小动物 SPECT/CT 成像显示在注射后 1 小时和 2 小时可以清晰地看到肿瘤。

结论

[I]I-pHLIP(Var7)可以在酸性环境下与 MDA-MB-231 细胞结合,并且在探针注射后 1 小时和 2 小时,小动物 SPECT/CT 成像显示出清晰的肿瘤。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59d4/7953584/6742fde0bb5b/MOI2021-5565932.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59d4/7953584/de5ee45152bc/MOI2021-5565932.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59d4/7953584/fe03f1512bce/MOI2021-5565932.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59d4/7953584/d8cecc7131aa/MOI2021-5565932.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59d4/7953584/b39cbd510a33/MOI2021-5565932.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59d4/7953584/f957495a2b1e/MOI2021-5565932.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59d4/7953584/6742fde0bb5b/MOI2021-5565932.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59d4/7953584/de5ee45152bc/MOI2021-5565932.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59d4/7953584/fe03f1512bce/MOI2021-5565932.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59d4/7953584/d8cecc7131aa/MOI2021-5565932.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59d4/7953584/b39cbd510a33/MOI2021-5565932.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59d4/7953584/f957495a2b1e/MOI2021-5565932.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59d4/7953584/6742fde0bb5b/MOI2021-5565932.006.jpg

相似文献

1
An Experimental Study on [I]I-pHLIP (Var7) for SPECT/CT Imaging of an MDA-MB-231 Triple-Negative Breast Cancer Mouse Model by Targeting the Tumor Microenvironment.靶向肿瘤微环境的 [I]I-pHLIP (Var7) 用于 SPECT/CT 成像 MDA-MB-231 三阴性乳腺癌小鼠模型的实验研究
Mol Imaging. 2021 Feb 16;2021:5565932. doi: 10.1155/2021/5565932. eCollection 2021.
2
Synthesis and Evaluation of Radioiodine-Labeled pH (Low) Insertion Peptide Variant 7-Like Peptide as a Noninvasive Tumor Microenvironment Imaging Agent in a Mouse MDA-MB-231 Triple-Negative Breast Cancer Model.放射性碘标记的pH(低)插入肽变体7样肽作为小鼠MDA-MB-231三阴性乳腺癌模型中非侵入性肿瘤微环境成像剂的合成与评价
Mol Imaging Biol. 2022 Aug;24(4):570-579. doi: 10.1007/s11307-021-01702-0. Epub 2022 Jan 10.
3
Inhibition of MDA-MB-231 cell proliferation by pHLIP(Var7)-P1AP and SPECT imaging of MDA-MB-231 breast cancer-bearing nude mice using 125I-pHLIP(Var7)-P1AP.pHLIP(Var7)-P1AP 抑制 MDA-MB-231 细胞增殖和 125I-pHLIP(Var7)-P1AP 用于荷 MDA-MB-231 乳腺癌裸鼠的 SPECT 成像。
Nuklearmedizin. 2021 Jun;60(3):240-248. doi: 10.1055/a-1307-1923. Epub 2021 Mar 23.
4
Synthesis and Evaluation of Technetium-99m-Labeled pH (Low) Insertion Peptide Variant 7 for Early Diagnosis of MDA-MB-231 Triple-Negative Breast Cancer by Targeting the Tumor Microenvironment.锝-99m标记的pH(低)插入肽变体7的合成与评估,用于通过靶向肿瘤微环境早期诊断MDA-MB-231三阴性乳腺癌
Front Oncol. 2022 Apr 21;12:869260. doi: 10.3389/fonc.2022.869260. eCollection 2022.
5
pHLIP(Var7)-P1AP suppresses tumor cell proliferation in MDA-MB-231 triple-negative breast cancer by targeting protease activated receptor 1.pHLIP(Var7)-P1AP 通过靶向蛋白酶激活受体 1 抑制 MDA-MB-231 三阴性乳腺癌细胞的增殖。
Breast Cancer Res Treat. 2020 Apr;180(2):379-384. doi: 10.1007/s10549-020-05560-2. Epub 2020 Feb 7.
6
In Vivo Distribution and Therapeutic Efficacy of Radioiodine-Labeled pH-Low Insertion Peptide Variant 3 in a Mouse Model of Breast Cancer.放射性碘标记的低 pH 插入肽变体 3 在乳腺癌小鼠模型中的体内分布和治疗效果。
Mol Imaging. 2022 Jul 4;2022:7456365. doi: 10.1155/2022/7456365. eCollection 2022.
7
SPECT/CT Imaging of the Novel HER2-Targeted Peptide Probe Tc-HYNIC-H6F in Breast Cancer Mouse Models.新型HER2靶向肽探针Tc-HYNIC-H6F在乳腺癌小鼠模型中的SPECT/CT成像
J Nucl Med. 2017 May;58(5):821-826. doi: 10.2967/jnumed.116.183863. Epub 2017 Jan 19.
8
MicroSPECT/CT Imaging of Cell-Line and Patient-Derived EGFR-Positive Tumor Xenografts in Mice with Panitumumab Fab Modified with Hexahistidine Peptides To Enable Labeling with Tc(I) Tricarbonyl Complex.使用六组氨酸肽修饰的帕尼单抗 Fab 进行 MicroSPECT/CT 成像,以实现 Tc(I)三羰基配合物标记,用于检测小鼠中细胞系和患者来源的 EGFR 阳性肿瘤异种移植物。
Mol Pharm. 2019 Aug 5;16(8):3559-3568. doi: 10.1021/acs.molpharmaceut.9b00422. Epub 2019 Jul 11.
9
Micro-SPECT/CT with 111In-DTPA-pertuzumab sensitively detects trastuzumab-mediated HER2 downregulation and tumor response in athymic mice bearing MDA-MB-361 human breast cancer xenografts.使用111铟-二乙三胺五乙酸-帕妥珠单抗的微型单光子发射计算机断层扫描/计算机断层扫描(Micro-SPECT/CT)能灵敏地检测携带MDA-MB-361人乳腺癌异种移植瘤的无胸腺小鼠中曲妥珠单抗介导的HER2下调和肿瘤反应。
J Nucl Med. 2009 Aug;50(8):1340-8. doi: 10.2967/jnumed.109.062224. Epub 2009 Jul 17.
10
Detection of breast cancer microcalcification using (99m)Tc-MDP SPECT or Osteosense 750EX FMT imaging.使用(99m)Tc-MDP单光子发射计算机断层扫描(SPECT)或Osteosense 750EX荧光分子断层扫描(FMT)成像检测乳腺癌微钙化。
Nucl Med Biol. 2015 Mar;42(3):269-73. doi: 10.1016/j.nucmedbio.2014.11.010. Epub 2014 Dec 6.

引用本文的文献

1
Innovative Approaches in the Synthesis and Optimization of Copper Complexes for Antitumor Therapies: A Comprehensive Review.用于抗肿瘤治疗的铜配合物合成与优化的创新方法:综述
Molecules. 2025 May 9;30(10):2104. doi: 10.3390/molecules30102104.
2
Small animal PET imaging with the Ga-labeled pH (low) insertion peptide-like peptide YJL-4 in a triple-negative breast cancer mouse model.在三阴性乳腺癌小鼠模型中使用镓标记的pH(低)插入肽样肽YJL-4进行小动物PET成像。
EJNMMI Radiopharm Chem. 2024 Apr 27;9(1):33. doi: 10.1186/s41181-024-00267-x.
3
Aiming the magic bullet: targeted delivery of imaging and therapeutic agents to solid tumors by pHLIP peptides.

本文引用的文献

1
pHLIP(Var7)-P1AP suppresses tumor cell proliferation in MDA-MB-231 triple-negative breast cancer by targeting protease activated receptor 1.pHLIP(Var7)-P1AP 通过靶向蛋白酶激活受体 1 抑制 MDA-MB-231 三阴性乳腺癌细胞的增殖。
Breast Cancer Res Treat. 2020 Apr;180(2):379-384. doi: 10.1007/s10549-020-05560-2. Epub 2020 Feb 7.
2
pH-triggered delivery of magnetic nanoparticles depends on tumor volume.pH 触发的磁性纳米颗粒递送取决于肿瘤体积。
Nanomedicine. 2020 Jan;23:102086. doi: 10.1016/j.nano.2019.102086. Epub 2019 Aug 23.
3
Peptides of pHLIP family for targeted intracellular and extracellular delivery of cargo molecules to tumors.
瞄准神奇子弹:通过pHLIP肽将成像和治疗剂靶向递送至实体瘤
Front Pharmacol. 2024 Mar 13;15:1355893. doi: 10.3389/fphar.2024.1355893. eCollection 2024.
4
In Vivo Distribution and Therapeutic Efficacy of Radioiodine-Labeled pH-Low Insertion Peptide Variant 3 in a Mouse Model of Breast Cancer.放射性碘标记的低 pH 插入肽变体 3 在乳腺癌小鼠模型中的体内分布和治疗效果。
Mol Imaging. 2022 Jul 4;2022:7456365. doi: 10.1155/2022/7456365. eCollection 2022.
5
Radionuclide imaging and therapy directed towards the tumor microenvironment: a multi-cancer approach for personalized medicine.针对肿瘤微环境的放射性核素成像与治疗:一种用于个体化医疗的多癌种方法。
Eur J Nucl Med Mol Imaging. 2022 Nov;49(13):4616-4641. doi: 10.1007/s00259-022-05870-1. Epub 2022 Jul 5.
6
Synthesis and Evaluation of Technetium-99m-Labeled pH (Low) Insertion Peptide Variant 7 for Early Diagnosis of MDA-MB-231 Triple-Negative Breast Cancer by Targeting the Tumor Microenvironment.锝-99m标记的pH(低)插入肽变体7的合成与评估,用于通过靶向肿瘤微环境早期诊断MDA-MB-231三阴性乳腺癌
Front Oncol. 2022 Apr 21;12:869260. doi: 10.3389/fonc.2022.869260. eCollection 2022.
pHLIP 家族肽用于将货物分子靶向递送至肿瘤的细胞内和细胞外。
Proc Natl Acad Sci U S A. 2018 Mar 20;115(12):E2811-E2818. doi: 10.1073/pnas.1715350115. Epub 2018 Mar 5.
4
Targeted imaging of urothelium carcinoma in human bladders by an ICG pHLIP peptide ex vivo.通过ICG pHLIP肽在体外对人膀胱尿路上皮癌进行靶向成像。
Proc Natl Acad Sci U S A. 2016 Oct 18;113(42):11829-11834. doi: 10.1073/pnas.1610472113. Epub 2016 Sep 29.
5
PET Imaging of Extracellular pH in Tumors with (64)Cu- and (18)F-Labeled pHLIP Peptides: A Structure-Activity Optimization Study.用(64)铜和(18)氟标记的pHLIP肽对肿瘤细胞外pH进行PET成像:一项构效关系优化研究。
Bioconjug Chem. 2016 Sep 21;27(9):2014-23. doi: 10.1021/acs.bioconjchem.6b00306. Epub 2016 Jul 21.
6
pH-Selective Cytotoxicity of pHLIP-Antimicrobial Peptide Conjugates.pH 选择性细胞毒性的 pHLIP-抗菌肽缀合物。
Sci Rep. 2016 Jun 23;6:28465. doi: 10.1038/srep28465.
7
OncomiR or Tumor Suppressor? The Duplicity of MicroRNAs in Cancer.致癌miRNA还是肿瘤抑制因子?微小RNA在癌症中的两面性
Cancer Res. 2016 Jul 1;76(13):3666-70. doi: 10.1158/0008-5472.CAN-16-0359. Epub 2016 Jun 20.
8
Comparative Study of Tumor Targeting and Biodistribution of pH (Low) Insertion Peptides (pHLIP(®) Peptides) Conjugated with Different Fluorescent Dyes.不同荧光染料偶联的pH(低)插入肽(pHLIP®肽)的肿瘤靶向性和生物分布的比较研究
Mol Imaging Biol. 2016 Oct;18(5):686-96. doi: 10.1007/s11307-016-0949-6.
9
The Inescapable Influence of Noncoding RNAs in Cancer.非编码RNA在癌症中不可避免的影响
Cancer Res. 2015 Dec 15;75(24):5206-10. doi: 10.1158/0008-5472.CAN-15-1989.
10
Down-regulation of PAR1 activity with a pHLIP-based allosteric antagonist induces cancer cell death.基于pHLIP的变构拮抗剂下调PAR1活性可诱导癌细胞死亡。
Biochem J. 2015 Dec 15;472(3):287-95. doi: 10.1042/BJ20150876. Epub 2015 Sep 30.